Welcome to our dedicated page for Perimeter Medical Imaging Ai news (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on Perimeter Medical Imaging Ai stock.
Perimeter Medical Imaging AI Inc (PYNKF) delivers cutting-edge imaging solutions for cancer surgery, specializing in AI-enhanced optical coherence tomography (OCT) systems. This page provides official updates on regulatory milestones, clinical research, and technological advancements shaping surgical oncology.
Investors and medical professionals will discover timely updates about the company’s FDA-cleared S-Series OCT platform, B-Series AI integration progress, and strategic partnerships. Content includes earnings reports, trial outcomes, and educational initiatives demonstrating real-world clinical impact.
Key updates cover surgical margin visualization innovations, regulatory submissions, and peer-reviewed study results. All materials are sourced directly from company filings and verified medical publications to ensure accuracy.
Bookmark this page for consolidated access to Perimeter’s latest developments in AI-driven surgical imaging. Regularly updated to reflect new achievements in precision oncology and operational growth.
Perimeter Medical Imaging AI, Inc. (OTC:PYNKF) reported its Q1 2022 financials, highlighting a net loss of
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK, OTC:PYNKF) announced participation in the ROTH Canada Showcase Day on May 17, 2022, in New York, NY. The company aims to transform cancer surgery using advanced imaging tools. A presentation will be led by CEO Jeremy Sobotta at 12:00 p.m. ET. Investors can register for the webcast here.
Perimeter Medical Imaging AI (TSX-V:PINK)(OTC:PYNKF) announced a conference call to discuss its financial results for the year ending
Perimeter Medical Imaging AI (OTC:PYNKF) reported its financial results for the year ended December 31, 2021, highlighting key developments in its commercial and clinical strategies. The Company achieved its first S-Series OCT installation, with guidance for 15-20 installations in 2022. Financially, operating expenses rose to $16.15 million, with a net loss of $16.64 million. Post-year-end, Perimeter raised approximately $48.7 million to strengthen its balance sheet. The Company is focused on ongoing clinical trials and expanding its product offerings to enhance patient outcomes.
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) announced its participation in key investor conferences aimed at enhancing its presence in the medical technology sector. The company will engage in one-on-one investor meetings and lead discussions focused on cancer-fighting technologies.
Notable events include the Lytham Partners Spring 2022 Investor Conference (April 4-7, 2022), NobleCon18 in Fort Lauderdale (April 19-21, 2022), and the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022. Perimeter specializes in advanced imaging tools to improve cancer surgery outcomes.
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK, OTC:PYNKF) has announced its participation in several upcoming medical conferences. These include the Society of Surgical Oncology’s International Conference in Dallas, TX (March 9-12, 2022), featuring a spotlight presentation on intraoperative margin visualization, and the National Consortium of Breast Centers’ Interdisciplinary Breast Center Conference in Las Vegas, NV (March 11-16, 2022). The company aims to showcase its advanced imaging tools designed to enhance cancer surgery outcomes. Further details can be found on Perimeter’s investors' website.
Perimeter Medical Imaging AI, Inc. (PYNKF) announces CEO Jeremy Sobotta will participate in the 34th Annual Roth Conference from March 13-15, 2022, in Dana Point, CA. Sobotta will hold one-on-one investor meetings and join a panel titled “Looking to Canadian Markets for Access to Public Venture Capital and Growth Investment Opportunities.” This event will showcase insights from companies leveraging public venture capital for growth. The discussion is scheduled for March 14, 2022, at 12:30 PM PT and will be webcast for broader access.
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK, OTC:PYNKF) announced key milestones in a corporate update, highlighting its FDA 510(k) clearance for the Perimeter S-Series OCT platform, enabling commercial launch. CEO Jeremy Sobotta noted a successful equity financing of C$48.7 million, boosting growth potential. The company initiated a multi-center clinical trial for the Perimeter B-Series OCT with ImgAssist AI, expected to complete in 2022. With strong backing from investors like Social Capital, Perimeter is set to advance its innovative imaging technologies in cancer surgery.
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) announced a corporate update and conference call scheduled for February 23, 2022, at 5 PM ET, led by CEO Jeremy Sobotta. The company, focused on transforming cancer surgery with advanced imaging technology, aims to address significant medical needs. The conference can be accessed via phone or an audio webcast. This session will provide investors with insights into the company’s developments in high-resolution imaging tools designed to assist in the fight against breast cancer.
FAQ
What is the current stock price of Perimeter Medical Imaging Ai (PYNKF)?
What is the market cap of Perimeter Medical Imaging Ai (PYNKF)?
